We examine the impact of NICE's decision not to approve a drug used for treating diabetic macular oedema, a condition that affects 50,000 people in the UK. Show more
Discover 11,128,835 listings and 278,310 playable programmes from the BBC
We examine the impact of NICE's decision not to approve a drug used for treating diabetic macular oedema, a condition that affects 50,000 people in the UK. Show more
Intelligent speech, the most insightful journalism, the wittiest comedy, the most fascinating features and the most compelling drama and readings anywhere in UK radio.
